oxazoles has been researched along with Diabetes Mellitus in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (65.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, JH; Hwang, HY; Jeon, YE; Kim, J; Kim, KH; Kwon, HJ; Lee, DJ; Lee, MS; Lim, H; Lim, YM; Pagire, H; Park, K | 1 |
| Bone, RN; Evans-Molina, C; Kono, T; Mosley, AL; Reissaus, CA; Sohn, P; Syed, F; Tong, X; True, JD; Wijeratne, AB; Yamamoto, WR | 1 |
| Chen, W; Li, S; Meng, A; Wang, L; Xie, X; Zhang, N; Zhou, X | 1 |
| Giri, S; Goel, A; Jain, M; Makadia, P; Patel, H; Patel, M; Patel, P; Pingali, H; Shah, S; Zaware, P | 1 |
| Ahmad, M; Bolin, D; Chen, Y; Cheung, AW; Conde-Knape, K; Firooznia, F; Guo, L; Hamilton, MM; Hayden, S; Huang, KS; Li, S; Marcopulos, N; McDermott, L; Pamidimukkala, A; Qian, Y; Ramsey, GB; Rondinone, CM; Tan, J; Taub, R; Tilley, J; Wertheimer, SJ; Whittard, T; Yun, W | 1 |
| Meredith, PA; Reid, JL | 1 |
| Brown, KK; Carrick, KM; Chen, L; Clifton, LG; McNulty, JA; Pahel, GL; Stimpson, SA; Strum, JC; Winegar, DA; Yang, B | 1 |
| Erlich, R | 1 |
| Ketelslegers, JM; Lambert, AE; Mpoy, M; Vandeleene, B | 1 |
| Beyer, J; Haupt, E; Köberich, W; Rosak, C; Schöffling, K | 1 |
| Beyer, J; Haupt, E; Schöffling, K | 1 |
| Gross, W | 1 |
| Birk, W; Petrides, P | 1 |
| Acksteiner, B; Kolb, KH; Mützel, W; Schulze, PE; Speck, U | 1 |
| Rambert, P | 1 |
| Beyer, J; Ewald, W; Grabs, V; Haupt, E; Petzoldt, R; Ramrath, M; Riedesel, G; Schöffling, K; Schwedes, U | 1 |
| Blumenbach, L; Kiesselbach, NH; Lehnert, J | 3 |
| Jacker, HJ | 1 |
| Geyer, G; Sokopp, B | 1 |
| Blickens, DA; Riggi, SJ | 1 |
| Beringer, A; Geyer, G; Tragl, KH | 1 |
1 review(s) available for oxazoles and Diabetes Mellitus
| Article | Year |
|---|---|
[Antidiabetics. 42].
Topics: Adolescent; Adult; Aged; Biguanides; Carbutamide; Child; Child, Preschool; Diabetes Mellitus; Diabetes Mellitus, Type 1; Glucosamine; Humans; Hypoglycemic Agents; Infant; Insulin; Insulin, Long-Acting; Middle Aged; Oxazoles; Plants, Medicinal; Pyrazoles; Quinolines; Sulfadiazine; Sulfathiazoles; Tolbutamide; Triazines; Urea | 1969 |
6 trial(s) available for oxazoles and Diabetes Mellitus
| Article | Year |
|---|---|
[Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide].
Topics: Aged; Antigens; Azepines; Biguanides; Blood Glucose; Depression, Chemical; Diabetes Mellitus; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Oxazoles; Sulfonylurea Compounds; Time Factors | 1974 |
[Progress in oral antidiabetic therapy].
Topics: Administration, Oral; Adult; Aged; Animals; Azepines; Clinical Trials as Topic; Diabetes Mellitus; Dogs; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Oxazoles; Rabbits; Rats; Sulfonylurea Compounds | 1973 |
[Clinical experience with the blood sugar reducing sulfonamide derivative glisoxepide].
Topics: Azepines; Carbutamide; Clinical Trials as Topic; Diabetes Mellitus; Drug Evaluation; Female; Glycosuria; Humans; Hypoglycemic Agents; Kidney; Male; Middle Aged; Oxazoles; Sulfonylurea Compounds; Time Factors; Tolbutamide | 1974 |
[Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). II. Proof of activity in the management of adult onset diabetes].
Topics: Adult; Aged; Azepines; Blood Glucose; Blood Pressure; Body Weight; Clinical Trials as Topic; Diabetes Mellitus; Drug Evaluation; Female; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Oxazoles; Statistics as Topic; Sulfonylurea Compounds; Time Factors | 1974 |
[Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). 1. Establishment of proof and methods].
Topics: Alkaline Phosphatase; Azepines; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus; Drug Evaluation; Drug Tolerance; Electrocardiography; Humans; Hypoglycemic Agents; Methods; Oxazoles; Research Design; Statistics as Topic; Sulfonylurea Compounds; Time Factors | 1974 |
[Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). 3. Results of tolerance tests].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Azepines; Blood Glucose; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Diabetes Mellitus; Drug Evaluation; Drug Hypersensitivity; Gastrointestinal Diseases; Humans; Hyperlipidemias; Hypoglycemic Agents; Kidney Diseases; Oxazoles; Paresthesia; Photosensitivity Disorders; Sulfonylurea Compounds; Time Factors | 1974 |
16 other study(ies) available for oxazoles and Diabetes Mellitus
| Article | Year |
|---|---|
A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes.
Topics: Animals; Autophagy; Diabetes Mellitus; HeLa Cells; Humans; Hypoglycemic Agents; Lipid Metabolism; Male; Metabolic Syndrome; Metabolome; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Obesity; Oxazoles; Stress, Physiological | 2018 |
Endoplasmic reticulum stress alters ryanodine receptor function in the murine pancreatic β cell.
Topics: Animals; Calcium Signaling; Cell Line; Diabetes Mellitus; Endoplasmic Reticulum Stress; Insulin-Secreting Cells; Macrocyclic Compounds; Male; Mice; Mice, Mutant Strains; Oxazoles; Ryanodine Receptor Calcium Release Channel; Tunicamycin; Unfolded Protein Response | 2019 |
C333H ameliorated insulin resistance through selectively modulating peroxisome proliferator-activated receptor γ in brown adipose tissue of db/db mice.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Blood Glucose; Cell Line, Tumor; Diabetes Mellitus; Furans; Gene Expression Regulation; Humans; Insulin; Insulin Resistance; Leptin; Male; Mice; Obesity; Organ Size; Oxazoles; PPAR gamma; Rats; Rats, Wistar; Sodium Glutamate | 2013 |
Design and synthesis of novel oxazole containing 1,3-dioxane-2-carboxylic acid derivatives as PPAR alpha/gamma dual agonists.
Topics: Animals; Carboxylic Acids; Diabetes Mellitus; Drug Design; Hypoglycemic Agents; Mice; Mice, Inbred NOD; Molecular Structure; Oxazoles; PPAR alpha; PPAR gamma; Rats; Rats, Zucker; Structure-Activity Relationship | 2008 |
Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes.
Topics: Administration, Oral; Amides; Animals; Carboxylic Acids; Cell Line; Diabetes Mellitus; Diacylglycerol O-Acyltransferase; Dogs; Drug Discovery; Enzyme Inhibitors; Ether-A-Go-Go Potassium Channels; Humans; Inhibitory Concentration 50; Male; Mice; Obesity; Oxazoles; Rats | 2011 |
Efficacy and tolerability of long-term rilmenidine treatment in hypertensive diabetic patients. A retrospective analysis of a general practice study.
Topics: Adult; Aged; Antihypertensive Agents; Biomarkers; Blood Pressure; Creatinine; Diabetes Mellitus; Diastole; Drug Therapy, Combination; Family Practice; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Oxazoles; Retrospective Studies; Rilmenidine; Systole; Time; Treatment Outcome; Triglycerides | 2004 |
Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats.
Topics: Adiponectin; Animals; Biomarkers; Carrier Proteins; Diabetes Mellitus; Fatty Acid-Binding Proteins; Insulin; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Lipids; Male; Obesity; Oxazoles; Pioglitazone; PPAR gamma; Rats; Rats, Sprague-Dawley; Rats, Zucker; Thiazolidinediones; Tyrosine | 2004 |
American Diabetes Association - 65th Scientific Sessions. PPAR agents.
Topics: Alkanesulfonates; Animals; Blood Glucose; Diabetes Mellitus; Glycine; Humans; Hypoglycemic Agents; Oxazoles; Peroxisome Proliferator-Activated Receptors; Phenylpropionates | 2005 |
Treatment of hypertension in diabetic patients.
Topics: Antihypertensive Agents; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Oxazoles; Rilmenidine | 1989 |
[Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients].
Topics: Adult; Azepines; Blood Glucose; Diabetes Mellitus; Drug Interactions; Fatty Acids, Nonesterified; Glucose; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Oxazoles; Stimulation, Chemical; Sulfonylurea Compounds; Tolbutamide | 1972 |
[Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
Topics: Administration, Oral; Autoanalysis; Azepines; Blood Glucose; Depression, Chemical; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Evaluation; Glyburide; Humans; Hypoglycemic Agents; Injections, Intravenous; Insulin; Oxazoles; Sulfonamides; Sulfonylurea Compounds; Time Factors; Tolbutamide | 1974 |
[Clinical experiences with prodiaban in diabetes mellitus].
Topics: Azepines; Blood Glucose; Body Weight; Diabetes Mellitus; Female; Glycosuria; Humans; Hypoglycemic Agents; Male; Middle Aged; Oxazoles; Sulfonylurea Compounds; Time Factors | 1974 |
[Pharmacokinetics and metabolite spectrum of glisoxepide in humans].
Topics: Adult; Aged; Azepines; Carbon Dioxide; Carbon Radioisotopes; Chromatography; Diabetes Mellitus; Drug Evaluation; Feces; Female; Half-Life; Humans; Hypoglycemic Agents; Kidney; Kinetics; Male; Middle Aged; Oxazoles; Spectrophotometry, Ultraviolet; Sulfonylurea Compounds; Sulfur Radioisotopes; Tritium | 1974 |
[Influence of 3,5-dimethylisoxazol short-term administration on the carbohydrate metabolism in elderly diabetics with secondary failure of sulfonylurea treatment].
Topics: Aged; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus; Fatty Acids, Nonesterified; Female; Glycosuria; Humans; Hypoglycemic Agents; Injections, Intramuscular; Injections, Intravenous; Male; Metformin; Middle Aged; Oxazoles; Time Factors; Tolbutamide | 1969 |
Carbohydrate metabolism in normal and hyperglycemic animals treated with 1-methyl-4-(3-methyl-5-isoxazolyl)pyridinium chloride and phenformin.
Topics: Animals; Blood Glucose; Carbamates; Carbohydrate Metabolism; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Fasting; Glucosamine; Glycogen; Glycosuria; Guinea Pigs; Hyperglycemia; Hypoglycemia; Lactates; Liver Glycogen; Male; Mice; Nitroso Compounds; Obesity; Oxazoles; Phenformin; Pyridinium Compounds; Rats | 1971 |
[The influence of plasma fatty acid reduction through 3,5-dimethylisoxazole, on carbohydrate metabolism. I. Lack of influence on insulin sensitivity in adult diabetics].
Topics: Adult; Age Factors; Blood Glucose; Diabetes Mellitus; Diet Therapy; Fatty Acids, Nonesterified; Female; Humans; Injections, Intravenous; Insulin; Male; Middle Aged; Oxazoles | 1968 |